ANTI-KIR COMBINATION TREATMENTS AND METHODS

ANTI-KIR COMBINATION TREATMENTS AND METHODS

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection), and methods of using the compositions.SOLUTION: The present invention provides compositions comprising anti-KIR (killer immunoglobulin-like r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROMAGNE FRANCOIS, WAGTMANN PETER ANDREAS NICOLAI REUMERT, JOAKIM GLAMANN
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ROMAGNE FRANCOIS
WAGTMANN PETER ANDREAS NICOLAI REUMERT
JOAKIM GLAMANN
description PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection), and methods of using the compositions.SOLUTION: The present invention provides compositions comprising anti-KIR (killer immunoglobulin-like receptor) antibodies and one or more secondary anti-cancer agents (interleukin-2, interleukin-2 derivatives, or interleukin-2 analogues) or anti-viral agents (interleukin-2 proteins etc.), and methods of using such combinations (as combination compositions or in separate administration protocols). The pharmaceuticals are free of Rituxan and Campath, and free of any other pharmaceutically active agents.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014132010A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014132010A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014132010A3</originalsourceid><addsrcrecordid>eNrjZNB29Avx1PX2DFJw9vd18vRzDPH091MICXJ1DPF19QsJVnD0c1HwdQ3x8HcJ5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGJobGQNLA0ZgoRQC93yVC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-KIR COMBINATION TREATMENTS AND METHODS</title><source>esp@cenet</source><creator>ROMAGNE FRANCOIS ; WAGTMANN PETER ANDREAS NICOLAI REUMERT ; JOAKIM GLAMANN</creator><creatorcontrib>ROMAGNE FRANCOIS ; WAGTMANN PETER ANDREAS NICOLAI REUMERT ; JOAKIM GLAMANN</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection), and methods of using the compositions.SOLUTION: The present invention provides compositions comprising anti-KIR (killer immunoglobulin-like receptor) antibodies and one or more secondary anti-cancer agents (interleukin-2, interleukin-2 derivatives, or interleukin-2 analogues) or anti-viral agents (interleukin-2 proteins etc.), and methods of using such combinations (as combination compositions or in separate administration protocols). The pharmaceuticals are free of Rituxan and Campath, and free of any other pharmaceutically active agents.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140717&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014132010A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140717&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014132010A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROMAGNE FRANCOIS</creatorcontrib><creatorcontrib>WAGTMANN PETER ANDREAS NICOLAI REUMERT</creatorcontrib><creatorcontrib>JOAKIM GLAMANN</creatorcontrib><title>ANTI-KIR COMBINATION TREATMENTS AND METHODS</title><description>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection), and methods of using the compositions.SOLUTION: The present invention provides compositions comprising anti-KIR (killer immunoglobulin-like receptor) antibodies and one or more secondary anti-cancer agents (interleukin-2, interleukin-2 derivatives, or interleukin-2 analogues) or anti-viral agents (interleukin-2 proteins etc.), and methods of using such combinations (as combination compositions or in separate administration protocols). The pharmaceuticals are free of Rituxan and Campath, and free of any other pharmaceutically active agents.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB29Avx1PX2DFJw9vd18vRzDPH091MICXJ1DPF19QsJVnD0c1HwdQ3x8HcJ5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGJobGQNLA0ZgoRQC93yVC</recordid><startdate>20140717</startdate><enddate>20140717</enddate><creator>ROMAGNE FRANCOIS</creator><creator>WAGTMANN PETER ANDREAS NICOLAI REUMERT</creator><creator>JOAKIM GLAMANN</creator><scope>EVB</scope></search><sort><creationdate>20140717</creationdate><title>ANTI-KIR COMBINATION TREATMENTS AND METHODS</title><author>ROMAGNE FRANCOIS ; WAGTMANN PETER ANDREAS NICOLAI REUMERT ; JOAKIM GLAMANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014132010A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROMAGNE FRANCOIS</creatorcontrib><creatorcontrib>WAGTMANN PETER ANDREAS NICOLAI REUMERT</creatorcontrib><creatorcontrib>JOAKIM GLAMANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROMAGNE FRANCOIS</au><au>WAGTMANN PETER ANDREAS NICOLAI REUMERT</au><au>JOAKIM GLAMANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-KIR COMBINATION TREATMENTS AND METHODS</title><date>2014-07-17</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection), and methods of using the compositions.SOLUTION: The present invention provides compositions comprising anti-KIR (killer immunoglobulin-like receptor) antibodies and one or more secondary anti-cancer agents (interleukin-2, interleukin-2 derivatives, or interleukin-2 analogues) or anti-viral agents (interleukin-2 proteins etc.), and methods of using such combinations (as combination compositions or in separate administration protocols). The pharmaceuticals are free of Rituxan and Campath, and free of any other pharmaceutically active agents.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2014132010A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTI-KIR COMBINATION TREATMENTS AND METHODS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T00%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROMAGNE%20FRANCOIS&rft.date=2014-07-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014132010A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true